Loading
Latest filing published 09 Mar 2023 for F-star Therapeutics, Inc., €209k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Darlene M. Deptula-Hicks on record concern F-star Therapeutics, Inc., in the capacity of finance chief. Over a trading history stretching from 20 November 2020 to 8 March 2023, the count stands at 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 9 March 2023 came the latest disclosure, a transaction for €209k in F-star Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations